BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 163.00
+3.30 (2.07%)
Jun 10, 2026, 4:09 PM HKT
BeOne Medicines AG Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,681 | 2,007 | -4,706 | -6,252 | -13,821 | -9,261 |
Depreciation & Amortization | 908.26 | 921.04 | 1,219 | 595.18 | 434.89 | 288.99 |
Other Amortization | 69 | 69.97 | 34.52 | 26.51 | 22.24 | 6.13 |
Asset Writedown & Restructuring Costs | -692.53 | -702.27 | -96.54 | -60.23 | -191.31 | -184.14 |
Loss (Gain) From Sale of Investments | 525.73 | 533.13 | 175.34 | 115.02 | 151.71 | -48.48 |
Stock-Based Compensation | 3,524 | 3,573 | 3,223 | 2,607 | 2,091 | 1,529 |
Other Operating Activities | -8.77 | 149.6 | 271.13 | -2,611 | 76.6 | 170.8 |
Change in Accounts Receivable | -1,138 | -1,154 | -2,405 | -1,335 | 2,098 | -2,687 |
Change in Inventory | -642.62 | -651.65 | -667.84 | -999.45 | -391 | -974.06 |
Change in Accounts Payable | 550.64 | 558.38 | 886.82 | 152.34 | -30.02 | 127.1 |
Change in Unearned Revenue | 8.92 | 9.04 | 4.62 | -1,812 | -1,047 | 2,590 |
Change in Other Net Operating Assets | 2,538 | 2,573 | 1,034 | 1,367 | 283.72 | 192.46 |
Operating Cash Flow | 9,323 | 7,887 | -1,026 | -8,207 | -10,322 | -8,250 |
Capital Expenditures | -1,191 | -1,300 | -3,596 | -3,984 | -2,245 | -1,670 |
Sale (Purchase) of Intangibles | -556.56 | -564.39 | -266.23 | -243.68 | -990.89 | -329.76 |
Investment in Securities | -639.91 | -58.67 | -119.35 | 4,668 | 10,675 | 6,070 |
Other Investing Activities | 74.21 | -8.65 | -20.89 | -14.71 | -10.24 | - |
Investing Cash Flow | -2,313 | -1,932 | -4,002 | 425.48 | 7,429 | 4,070 |
Short-Term Debt Issued | - | 1,634 | 6,338 | 4,691 | 2,164 | 2,582 |
Long-Term Debt Issued | - | 5,949 | 66.08 | 159.56 | 257.76 | 106.97 |
Total Debt Issued | 7,305 | 7,584 | 6,404 | 4,850 | 2,422 | 2,689 |
Short-Term Debt Repaid | - | -7,308 | -5,140 | -2,195 | -2,877 | -2,044 |
Long-Term Debt Repaid | - | -249.56 | -204.6 | -97.07 | - | - |
Total Debt Repaid | -6,225 | -7,557 | -5,345 | -2,292 | -2,877 | -2,044 |
Net Debt Issued (Repaid) | 1,080 | 26.59 | 1,059 | 2,558 | -454.77 | 645 |
Issuance of Common Stock | 1,060 | 1,373 | 331.18 | 395.05 | 323.92 | 22,459 |
Repurchase of Common Stock | -166.88 | -169.23 | - | - | - | - |
Other Financing Activities | 6,077 | 6,180 | 21.9 | - | - | - |
Financing Cash Flow | 8,051 | 7,410 | 1,412 | 2,953 | -130.85 | 23,104 |
Foreign Exchange Rate Adjustments | 270.74 | 419.83 | -377.4 | -57.31 | -478.55 | 89.16 |
Net Cash Flow | 15,332 | 13,785 | -3,994 | -4,886 | -3,503 | 19,013 |
Free Cash Flow | 8,132 | 6,587 | -4,622 | -12,192 | -12,567 | -9,921 |
Free Cash Flow Margin | 20.67% | 17.63% | -16.62% | -69.93% | -128.68% | -132.76% |
Free Cash Flow Per Share | 69.71 | 58.06 | -43.90 | -116.79 | -121.85 | -106.92 |
Cash Interest Paid | 361.78 | 366.87 | 373.53 | 140.07 | 173.6 | 190.37 |
Cash Income Tax Paid | 379.42 | 704.2 | 506.78 | 397.11 | 203.47 | 99.7 |
Levered Free Cash Flow | - | 4,982 | -2,707 | -9,031 | -6,509 | -7,648 |
Unlevered Free Cash Flow | - | 5,236 | -2,608 | -9,012 | -6,426 | -7,536 |
Change in Working Capital | 1,317 | 1,335 | -1,147 | -2,627 | 913.13 | -751.8 |